Evidence map›Paper›PMID 39122463›Full record

ReviewBMJ global health2024

Frailty: a global health challenge in need of local action.

Schenelle Dayna Dlima, Alex Hall, Abodunrin Quadri Aminu, Asangaedem Akpan, Chris Todd, Emma R L C Vardy

Abstract readReview
In one paragraph

Review in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Cardiovascular frailty - an emerging frailty phenotype.Journal of human hypertension · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Rethinking Health System Readiness for Frailty Management: Frontline Perspectives from Indonesia and Malaysia.Health care analysis : HCA : journal of health philosophy and policy · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Schenelle Dayna DlimaSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK schenelle.dlima@postgrad.manchester.ac.uk.ORCID http://orcid.org/0000-0003-2782-6972
Alex HallSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Abodunrin Quadri AminuSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Asangaedem AkpanBunbury Regional Hospital, Bunbury, Western Australia, Australia.
Chris ToddSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Emma R L C VardySchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty is a complex, age-related clinical condition that involves multiple contributing factors and raises the risk of adverse outcomes in older people. Given global population ageing trends, the growing prevalence and incidence of frailty pose significant challenges to health and social care systems in both high-income and lower-income countries. In this review, we highlight the disproportionate representation of research on frailty screening and management from high-income countries, despite how lower-income countries are projected to have a larger share of older people aged ≥60. However, more frailty research has been emerging from lower-income countries in recent years, paving the way for more context-specific guidelines and studies that validate frailty assessment tools and evaluate frailty interventions in the population. We then present further considerations for contextualising frailty in research and practice in lower-income countries. First, the heterogeneous manifestations of frailty call for research that reflects different geographies, populations, health systems, community settings and policy priorities; this can be driven by supportive collaborative systems between high-income and lower-income countries. Second, the global narrative around frailty and ageing needs re-evaluation, given the negative connotations linked with frailty and the introduction of intrinsic capacity by the World Health Organization as a measure of functional reserves throughout the life course. Finally, the social determinants of health as possible risk factors for frailty in lower-income countries and global majority populations, and potential socioeconomic threats of frailty to national economies warrant proactive frailty screening in these populations.

Indexed as

FrailtyGlobal HealthAgedAged, 80 and overAgingDeveloping CountriesFrail ElderlyGeriatric AssessmentHumansSocial Determinants of HealthGlobal HealthHealth policyPublic Health

Identifiers

PMID39122463
PMCPMC11331888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.